CyGenica

Biotech startup CyGenica Gets Funding From SOSV to Accelerate Cancer and Rare Genetic Disease Therapy

CyGenica's disruptive technology addresses the problem of delivering large-molecule therapeutics into living cells without damaging them or triggering an adverse immune response.